Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 207620

Expand all

ENTRESTO (SACUBITRIL; VALSARTAN)
24MG;26MG
Marketing Status: Prescription
Active Ingredient: SACUBITRIL; VALSARTAN
Proprietary Name: ENTRESTO
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 24MG;26MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N207620
Product Number: 001
Approval Date: Jul 7, 2015
Applicant Holder Full Name: NOVARTIS PHARMACEUTICALS CORP
Marketing Status:  Prescription
Patent and Exclusivity Information
ENTRESTO (SACUBITRIL; VALSARTAN)
49MG;51MG
Marketing Status: Prescription
Active Ingredient: SACUBITRIL; VALSARTAN
Proprietary Name: ENTRESTO
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 49MG;51MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N207620
Product Number: 002
Approval Date: Jul 7, 2015
Applicant Holder Full Name: NOVARTIS PHARMACEUTICALS CORP
Marketing Status:  Prescription
Patent and Exclusivity Information
ENTRESTO (SACUBITRIL; VALSARTAN)
97MG;103MG
Marketing Status: Prescription
Active Ingredient: SACUBITRIL; VALSARTAN
Proprietary Name: ENTRESTO
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 97MG;103MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: 
Application Number: N207620
Product Number: 003
Approval Date: Jul 7, 2015
Applicant Holder Full Name: NOVARTIS PHARMACEUTICALS CORP
Marketing Status:  Prescription
Patent and Exclusivity Information

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English